The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prospective validation of genetic predictors of aromatase inhibitor-associated musculoskeletal symptoms (AIMSS) in a racially diverse cohort: Results from ECOG-ACRIN E1Z11.
 
Vered Stearns
Research Funding - Abbvie (Inst); Biocept (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst)
Other Relationship - Immunomedics
 
Opeyemi Jegede
No Relationships to Disclose
 
Victor Tsu-Shih Chang
Research Funding - Incyte (Inst)
 
Todd C. Skaar
Honoraria - Tabula Rasa Healthcare
Consulting or Advisory Role - Indiana University Health
Travel, Accommodations, Expenses - Tabula Rasa Healthcare
Other Relationship - NIH
 
Jeffrey L. Berenberg
Stock and Other Ownership Interests - Abbvie (I)
Research Funding - Amgen (Inst); E.R. Squibb Sons, LLC (Inst)
 
Ranveer Nand
Travel, Accommodations, Expenses - Ascension
 
Alan P. Lyss
No Relationships to Disclose
 
Nisha Lassi Jacobs
No Relationships to Disclose
 
William E. Luginbuhl
No Relationships to Disclose
 
Paul Gilman
No Relationships to Disclose
 
Al Benson
No Relationships to Disclose
 
Judie R. Goodman
No Relationships to Disclose
 
Gary L Buchschacher
Research Funding - AstraZeneca (Inst); Merck (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Roche/Genentech
 
Norah Lynn Henry
Research Funding - Abbvie (Inst); Pfizer (Inst)
 
Charles L. Loprinzi
Consulting or Advisory Role - Asahi Kasei; Disarm Therapeutics; Metys Pharmaceuticals; Mitsubishi Tanabe Pharma; NKMax; OnQuality Pharmaceuticals; PledPharma
Research Funding - Bristol-Myers Squibb (Inst)
Other Relationship - Cynosure/Hologic
 
Patrick J. Flynn
Employment - Sanofi (I)
Stock and Other Ownership Interests - Celgene; Pfizer; Sanofi (I)
Consulting or Advisory Role - Dava Oncology
 
Edith P. Mitchell
Leadership - Corvus Pharmaceuticals
Honoraria - Sanofi
Consulting or Advisory Role - Bristol Myers Squib; Genentech; Merck; Novartis
Speakers' Bureau - Ipsen
Research Funding - Genentech (Inst); sanofi (Inst)
 
Michael Jordan Fisch
Employment - AIM Specialty Health
Stock and Other Ownership Interests - Anthem
Patents, Royalties, Other Intellectual Property - Healthcore, Inc. A subsidiary of Anthem, Inc.
 
Joseph A. Sparano
Stock and Other Ownership Interests - Metastat
Consulting or Advisory Role - Adgero Biopharmaceuticals; AstraZeneca; BMSi; Cardinal Health; Celgene; Celldex; CStone Pharmaceuticals; Daiichi Sankyo; Epic Sciences; Genentech/Roche; GlaxoSmithKline; Juno Therapeutics; Lilly; Merrimack; Novartis; Pfizer; Pfizer; Prescient Therapeutics
Speakers' Bureau - Certara Inc; Eisai
Research Funding - Deciphera (Inst); Genentech/Roche (Inst); Merck (Inst); Merrimack (Inst); Novartis (Inst); Novartis (Inst); Olema Pharmaceuticals (Inst); Prescient Therapeutics (Inst); Radius Health (Inst)
Travel, Accommodations, Expenses - Adgero Biopharmaceuticals; AstraZeneca; Menarini Silicon Biosystems; Myriad Genetics; Pfizer; Rhenium Medical; Roche/Genentech
 
Lynne I. Wagner
Stock and Other Ownership Interests - Gilead Sciences (I); Johnson & Johnson (I); Lilly (I)
Consulting or Advisory Role - Athenex; Celgene
Travel, Accommodations, Expenses - Celgene